Sarah Alummootil, BS, MS
Sarah operationally manages early access requests for N. America, S. America, Asia, and Europe. Prior to joining Early Access Care in 2017, Sarah worked with the Compassionate Access group at Pfizer Inc. Sarah is a Patient and Caregiver Advisory Board Coordinator for rare diseases. She has first-hand experience with global complexities of Expanded Access and Named Patient program execution. Sarah has conducted expanded access policy benchmarking assessments across the top 100 pharmaceutical companies and has guided policy and process development for small, mid, and large pharma companies based in the US, Europe, and Asia. Sarah is a graduate of Drexel University, for her Bachelor of Science and has a Master in Science from Georgetown University.